Bristol-Myers, Ono Denied High Court Look at Inventorship Ruling

May 24, 2021, 1:42 PM

Bristol-Myers Squibb Co. and Ono Pharmaceuticals Co. failed to convince the U.S. Supreme Court to review a Federal Circuit ruling that a Nobel Prize winner’s fellow researchers were properly added as co-inventors on his cancer immunotherapy patents.

The U.S. Court of Appeals for the Federal Circuit sided with Dana-Farber Cancer Institute, which argued that the researchers—Gordon Freeman and Clive R. Wood—should be listed as co-inventors with Tasuku Honjo. The lower court ruling allows Dana-Farber, Freeman’s employer, to license the patented technology, embodied in several of the newest immunotherapy drugs.

The drug companies told the Supreme Court the Federal Circuit improperly ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.